Jakafi ^*

Jakafi is a prescription medication primarily used to treat adults with intermediate or high-risk myelofibrosis, a type of bone marrow cancer. It is also prescribed for polycythemia vera after other treatments have failed, and for acute and chronic graft-versus-host disease (GVHD) in patients 12 years and older. It helps manage symptoms like an enlarged spleen, fatigue, and night sweats associated with these serious conditions.

Jakafi may begin to improve symptoms within the first few weeks of treatment. Many patients notice a reduction in spleen size and relief from symptoms like itching and night sweats within the first one to three months. However, the exact timing can vary for each individual. Consistent use as prescribed by your doctor is essential to achieve the best results and properly manage your condition over time.

Jakafi does not provide a cure for myelofibrosis or other conditions it treats. Instead, it is a targeted therapy designed to manage the disease effectively. It works by reducing the symptoms, such as an enlarged spleen and fatigue, and can help slow the progression of the disease. This action can significantly improve a patient’s quality of life while they are on the medication.

Jakafi should be taken as prescribed, but if you miss a dose, do not take an extra one to make up for it. Simply skip the missed dose and take your next dose at the regularly scheduled time. Taking two doses at once can increase your risk of side effects. If you frequently miss doses, speak with your doctor for advice on how to stay on track with your treatment plan.

Jakafi can suppress the immune system by inhibiting JAK enzymes, which are involved in immune function. This can make you more susceptible to infections, including serious bacterial, fungal, or viral infections. Your doctor will monitor you for any signs of infection while you are taking this medication. It is important to report any symptoms like fever, chills, or sore throat to your healthcare provider immediately.

You should not stop taking Jakafi suddenly without first consulting your doctor. Abruptly stopping the medication can cause a rapid return or worsening of your symptoms, sometimes more severe than before you started treatment. Your doctor will provide specific instructions on how to safely lower your dose over time if you need to discontinue the medication for any reason, such as for surgery or due to side effects.

Yes, you will need regular blood tests while taking Jakafi. Your doctor will order complete blood counts (CBCs) before you start treatment and frequently throughout your therapy. These tests are crucial for monitoring your platelet, red blood cell, and white blood cell levels. The results help your doctor ensure the medication is working safely and allow them to adjust your dosage as needed to manage potential side effects.

Jakafi is not a traditional chemotherapy drug but is considered a targeted therapy. While chemotherapy typically kills all rapidly dividing cells, both cancerous and healthy, Jakafi works differently. It specifically targets the JAK signaling pathways that are overactive in certain myeloproliferative neoplasms. This more focused approach helps control the disease with a different side effect profile than conventional chemotherapy. It is still a powerful cancer treatment.

Jakafi should be stored at room temperature, between 68°F to 77°F (20°C to 25°C). Keep the tablets in their original container with the lid tightly closed to protect them from moisture and light. As with all medications, it is important to store Jakafi in a safe place that is out of reach of children and pets to prevent accidental ingestion.

Jakafi may have its effects on the liver compounded by alcohol. It is generally recommended to limit alcohol consumption while taking this medication. Alcohol can put additional stress on the liver, and since Jakafi can also affect liver function, combining them could increase this risk. Always discuss your alcohol use with your doctor to understand the specific risks based on your overall health and treatment plan.

The most common side effects of Jakafi are related to its effects on blood cells. These include thrombocytopenia (low platelets), which causes bruising, and anemia (low red blood cells), which causes fatigue. Other frequently reported side effects are diarrhea, headache, and dizziness. Most side effects are manageable and can be addressed by your doctor, who may adjust your dose if necessary.

Jakafi is not typically associated with weight gain; in fact, weight loss is a common symptom of myelofibrosis, the condition it treats. Some patients may experience a stabilization or slight increase in weight as their symptoms improve and their appetite returns to normal. If you experience significant or unexpected weight changes while taking Jakafi, you should discuss it with your healthcare provider to determine the cause.